• Manuel S. Eisenberg

Chemotherapy in the bladder an option when BCG fails in treatment of superficial bladder cancer

A course of BCG bacteria in the bladder over 6 weeks is the standard of care for treatment of intermediate or high-risk superficial bladder cancer (<T2). When this treatment fails, a recent study demonstrates that a combination of Gemcitabine and Docetaxel in the bladder may be an appropriate next step. One and 2-year recurrence-free survival rates with the chemotherapy regimen were 60% and 46%, respectively. Only 3.6%) had disease progression on transurethral resection, and 15.6% went on to cystectomy (median 11.3 months from induction), of whom 4.0% had progression to muscle invasion. More study is needed, but this regimen may become standard of care in the future.


https://www.auajournals.org/doi/10.1097/JU.0000000000000688

Recent Posts

See All

DR. MANUEL S. EISENBERG, MD

Address

690 E Warner Rd, Bldg 5

Gilbert, AZ, 85296

Contact

Phone: (480) 664-0261

Fax: (480) 664-0281